These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24947148)

  • 1. Demodex and skin disease - false creation or palpable form?
    Hay RJ
    Br J Dermatol; 2014 Jun; 170(6):1214-5. PubMed ID: 24947148
    [No Abstract]   [Full Text] [Related]  

  • 2. Type VII collagen and squamous cell carcinoma.
    O'Toole EA
    Br J Dermatol; 2014 Jun; 170(6):1215. PubMed ID: 24947149
    [No Abstract]   [Full Text] [Related]  

  • 3. High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion.
    Pourreyron C; Chen M; McGrath JA; Salas-Alanis JC; South AP; Leigh IM
    Br J Dermatol; 2014 Jun; 170(6):1256-65. PubMed ID: 24641191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.
    Rodeck U; Uitto J
    J Invest Dermatol; 2007 Oct; 127(10):2295-6. PubMed ID: 17853916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita.
    Watanabe M; Natsuga K; Shinkuma S; Shimizu H
    J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
    Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
    J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
    South AP; O'Toole EA
    Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
    J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa.
    Cutlar L; Zhou D; Hu X; Duarte B; Greiser U; Larcher F; Wang W
    Exp Dermatol; 2016 Oct; 25(10):818-20. PubMed ID: 27117059
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.
    Kim M; Murrell DF
    Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular expression of type VII collagen in squamous cell carcinoma complicating dystrophic epidermolysis bullosa.
    Kanitakis J; Barthélémy H; Faure M; Claudy A
    Br J Dermatol; 1997 Aug; 137(2):310-3. PubMed ID: 9292093
    [No Abstract]   [Full Text] [Related]  

  • 12. A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa.
    Cuadrado-Corrales N; Sánchez-Jimeno C; García M; Ayuso C; De Lucas R; Vicario JL; Conti CJ; Zambruno G; Escamez MJ; Del Rio M
    Dermatology; 2011; 223(3):219-21. PubMed ID: 21849769
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
    Perdoni C; Osborn MJ; Tolar J
    Transl Res; 2016 Feb; 168():50-58. PubMed ID: 26073463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy for a genetic skin disease.
    Bruckner-Tuderman L
    N Engl J Med; 2010 Aug; 363(7):680-2. PubMed ID: 20818860
    [No Abstract]   [Full Text] [Related]  

  • 15. Type VII collagen is required for Ras-driven human epidermal tumorigenesis.
    Ortiz-Urda S; Garcia J; Green CL; Chen L; Lin Q; Veitch DP; Sakai LY; Lee H; Marinkovich MP; Khavari PA
    Science; 2005 Mar; 307(5716):1773-6. PubMed ID: 15774758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen.
    van den Akker PC; Mellerio JE; Martinez AE; Liu L; Meijer R; Dopping-Hepenstal PJ; van Essen AJ; Scheffer H; Hofstra RM; McGrath JA; Jonkman MF
    J Med Genet; 2011 Mar; 48(3):160-7. PubMed ID: 21113014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the COL7A1 gene results in a unique phenotype of epidermolysis bullosa pruriginosa.
    Ni C; Zhang J; Zhang H; Cheng RH; Liang JY; Li CX; Li M; Yao ZR
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):535-6. PubMed ID: 25556825
    [No Abstract]   [Full Text] [Related]  

  • 18. Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Rodeck U; Fertala A; Uitto J
    Exp Dermatol; 2007 Jun; 16(6):465-7. PubMed ID: 17518985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer. An anchor for tumor cell invasion.
    Yuspa SH; Epstein EH
    Science; 2005 Mar; 307(5716):1727-8. PubMed ID: 15774745
    [No Abstract]   [Full Text] [Related]  

  • 20. Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo.
    Woodley DT; Keene DR; Atha T; Huang Y; Ram R; Kasahara N; Chen M
    Mol Ther; 2004 Aug; 10(2):318-26. PubMed ID: 15294178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.